SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

UPL gains on introducing two new insecticides in North American Market

26 May 2023 Evaluate

UPL is currently trading at Rs. 682.05, up by 6.35 points or 0.94% from its previous closing of Rs. 675.70 on the BSE.

The scrip opened at Rs. 676.00 and has touched a high and low of Rs. 684.95 and Rs. 676.00 respectively. So far 6145 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 807.00 on 05-Dec-2022 and a 52 week low of Rs. 607.80 on 23-Jun-2022.

Last one week high and low of the scrip stood at Rs. 685.45 and Rs. 662.00 respectively. The current market cap of the company is Rs. 51161.42 crore.

The promoters holding in the company stood at 32.35%, while Institutions and Non-Institutions held 53.09% and 10.62% respectively.

UPL has introduced SHENZI 700 WG and SHENZI 400 SC insecticides in the North American market. SHENZI 700 WG and 400 SC provide growers with proven solutions to protect crops against insect pests and resistance while minimizing environmental impacts. 

The powerful active ingredient chlorantraniliprole targets pests while having minimal impact on beneficial insect populations, such as honeybees and other pollinators. SHENZI’s concentrated formulation allows lower dosage, less packaging and reduced storage space to improve efficiency, ease handling and reduce farmer costs. 

UPL is global player of crop protection products has customer base in 123 countries. It has subsidiary offices in Argentina, Australia, Bangladesh, Brazil, China, Canada, Denmark, Indonesia, France, Hong Kong, Japan, Korea, Mauritius, Mexico, New Zealand, Russia, Spain, Taiwan, South Africa, USA, UK, Vietnam and Zambia.

UPL Share Price

664.50 -0.50 (-0.08%)
20-Apr-2026 12:53 View Price Chart
Peers
Company Name CMP
UPL 664.50
PI Industries 3085.05
Bayer CropScience 4851.90
Sharda Cropchem 1110.20
Sumitomo Chemical 439.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×